Darlene H. Moak

2.5k total citations · 1 hit paper
26 papers, 2.0k citations indexed

About

Darlene H. Moak is a scholar working on Epidemiology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Darlene H. Moak has authored 26 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 8 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in Darlene H. Moak's work include Substance Abuse Treatment and Outcomes (17 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Alcoholism and Thiamine Deficiency (5 papers). Darlene H. Moak is often cited by papers focused on Substance Abuse Treatment and Outcomes (17 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Alcoholism and Thiamine Deficiency (5 papers). Darlene H. Moak collaborates with scholars based in United States and United Kingdom. Darlene H. Moak's co-authors include Raymond F. Anton, Patricia K. Latham, Raymond F. Anton, Robert Malcolm, L. Randolph Waid, James K. Dias, Konstantin Voronin, James S. Roberts, David J. Drobes and Henry R. Kranzler and has published in prestigious journals such as American Journal of Psychiatry, Psychopharmacology and Alcoholism Clinical and Experimental Research.

In The Last Decade

Darlene H. Moak

26 papers receiving 1.9k citations

Hit Papers

The Obsessive Compulsive Drinking Scale: A Self‐Rated Ins... 1995 2026 2005 2015 1995 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darlene H. Moak United States 19 1.1k 654 478 409 340 26 2.0k
Patricia K. Latham United States 22 1.2k 1.0× 619 0.9× 421 0.9× 406 1.0× 411 1.2× 28 2.1k
Kirsten C. Morley Australia 28 736 0.7× 851 1.3× 342 0.7× 607 1.5× 267 0.8× 107 2.5k
Konstantin Voronin United States 19 731 0.7× 898 1.4× 277 0.6× 154 0.4× 254 0.7× 26 1.8k
Jan Balldin Sweden 25 339 0.3× 577 0.9× 189 0.4× 218 0.5× 394 1.2× 79 1.9k
Alan Gordon United States 14 531 0.5× 329 0.5× 129 0.3× 295 0.7× 175 0.5× 24 1.3k
John Krystal United States 20 380 0.3× 853 1.3× 139 0.3× 565 1.4× 134 0.4× 34 2.0k
Megan L. Ryan United States 14 523 0.5× 439 0.7× 253 0.5× 199 0.5× 111 0.3× 16 1.2k
W. Feuerlein Germany 15 325 0.3× 625 1.0× 186 0.4× 257 0.6× 195 0.6× 82 1.7k
Kelly E. Courtney United States 22 684 0.6× 810 1.2× 196 0.4× 296 0.7× 70 0.2× 64 2.1k
Spencer Bujarski United States 25 773 0.7× 638 1.0× 237 0.5× 143 0.3× 61 0.2× 49 1.5k

Countries citing papers authored by Darlene H. Moak

Since Specialization
Citations

This map shows the geographic impact of Darlene H. Moak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darlene H. Moak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darlene H. Moak more than expected).

Fields of papers citing papers by Darlene H. Moak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darlene H. Moak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darlene H. Moak. The network helps show where Darlene H. Moak may publish in the future.

Co-authorship network of co-authors of Darlene H. Moak

This figure shows the co-authorship network connecting the top 25 collaborators of Darlene H. Moak. A scholar is included among the top collaborators of Darlene H. Moak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darlene H. Moak. Darlene H. Moak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Latham, Patricia K., et al.. (2007). What Role Does Measuring Medication Compliance Play in Evaluating the Efficacy of Naltrexone?. Alcoholism Clinical and Experimental Research. 31(4). 596–603. 50 indexed citations
2.
Kranzler, Henry R., Timothy Mueller, Jack R. Cornelius, et al.. (2006). Sertraline Treatment of Co-occurring Alcohol Dependence and Major Depression. Journal of Clinical Psychopharmacology. 26(1). 13–20. 73 indexed citations
3.
Malcolm, Robert, Steven D. LaRowe, Darlene H. Moak, et al.. (2005). A controlled trial of amlodipine for cocaine dependence: A negative report. Journal of Substance Abuse Treatment. 28(2). 197–204. 18 indexed citations
4.
Anton, Raymond F., Darlene H. Moak, Patricia K. Latham, et al.. (2005). Naltrexone Combined With Either Cognitive Behavioral or Motivational Enhancement Therapy for Alcohol Dependence. Journal of Clinical Psychopharmacology. 25(4). 349–357. 88 indexed citations
5.
Ham, Lindsay S., Maureen H. Carrigan, Darlene H. Moak, & Carrie L. Randall. (2005). Social Anxiety and Specificity of Positive Alcohol Expectancies: Preliminary Findings. Journal of Psychopathology and Behavioral Assessment. 27(2). 115–121. 16 indexed citations
6.
Moak, Darlene H.. (2004). Assessing the efficacy of medical treatments for alcohol use disorders. Expert Opinion on Pharmacotherapy. 5(10). 2075–2089. 5 indexed citations
7.
Litten, Raye Z., et al.. (2004). Pharmacological Treatment of Alcohol Abuse/Dependence With Psychiatric Comorbidity. Alcoholism Clinical and Experimental Research. 28(2). 302–312. 47 indexed citations
8.
Covault, Jonathan, Helen M. Pettinati, Darlene H. Moak, Timothy Mueller, & Henry R. Kranzler. (2004). Association of a long‐chain fatty acid‐CoA ligase 4 gene polymorphism with depression and with enhanced niacin‐induced dermal erythema. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 127B(1). 42–47. 46 indexed citations
9.
Anton, Raymond F., et al.. (2004). Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology. 173(1-2). 32–40. 118 indexed citations
10.
Nellissery, Maggie, Richard Feinn, Jonathan Covault, et al.. (2003). Alleles of a Functional Serotonin Transporter Promoter Polymorphism Are Associated With Major Depression in Alcoholics. Alcoholism Clinical and Experimental Research. 27(9). 1402–1408. 36 indexed citations
11.
Moak, Darlene H., et al.. (2003). Sertraline and Cognitive Behavioral Therapy for Depressed Alcoholics: Results of A Placebo-Controlled Trial. Journal of Clinical Psychopharmacology. 23(6). 553–562. 88 indexed citations
12.
Malcolm, Robert, et al.. (2002). Clinical Applications of Modafinil in Stimulant Abusers: Low Abuse Potential. American Journal on Addictions. 11(3). 247–249. 34 indexed citations
13.
Anton, Raymond F., Darlene H. Moak, Patricia K. Latham, et al.. (2001). Posttreatment Results of Combining Naltrexone with Cognitive-Behavior Therapy for the Treatment of Alcoholism. Journal of Clinical Psychopharmacology. 21(1). 72–77. 73 indexed citations
14.
Roberts, James S., Raymond F. Anton, Patricia K. Latham, & Darlene H. Moak. (1999). Factor Structure and Predictive Validity of the Obsessive Compulsive Drinking Scale. Alcoholism Clinical and Experimental Research. 23(9). 1484–1491. 96 indexed citations
15.
Anton, Raymond F., Darlene H. Moak, L. Randolph Waid, et al.. (1999). Naltrexone and Cognitive Behavioral Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial. American Journal of Psychiatry. 156(11). 1758–1764. 351 indexed citations
16.
Anton, Raymond F., et al.. (1997). A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal. Psychopharmacology. 131(2). 123–129. 10 indexed citations
17.
Anton, Raymond F., Darlene H. Moak, & Patricia K. Latham. (1996). Carbohydrate‐Deficient Transferrin as an Indicator of Drinking Status During a Treatment Outcome Study. Alcoholism Clinical and Experimental Research. 20(5). 841–846. 47 indexed citations
18.
Moak, Darlene H. & Raymond F. Anton. (1996). ALCOHOL-RELATED SEIZURES AND THE KINDLING EFFECT OF REPEATED DETOXIFICATIONS: THE INFLUENCE OF COCAINE. Alcohol and Alcoholism. 31(2). 135–143. 31 indexed citations
19.
Anton, Raymond F., Darlene H. Moak, & Patricia K. Latham. (1995). The Obsessive Compulsive Drinking Scale: A Self‐Rated Instrument for the Quantification of Thoughts about Alcohol and Drinking Behavior. Alcoholism Clinical and Experimental Research. 19(1). 92–99. 557 indexed citations breakdown →
20.
Anton, Raymond F. & Darlene H. Moak. (1994). Carbohydrate‐Deficient Transferrin and γ‐Glutamyltransferase as Markers of Heavy Alcohol Consumption: Gender Differences. Alcoholism Clinical and Experimental Research. 18(3). 747–754. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026